CCK and myocardial infarction: However, CCK-8 administration, a sulfated carboxyterminal octapeptide and a major bioactive segment of CCK improved the ventricular function and attenuated myocardial fibrosis and ventricular remodeling in an animal study of myocardial infarction [215].